Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Lipid metabolism regulation genes" refers to a broad set of genes involved in controlling the synthesis, breakdown, transport, and storage of lipids within cells and tissues. This category includes enzymes responsible for biosynthetic steps (such as fatty acid synthase), transporters mediating movement across membranes (such as ABCA1), nuclear receptors/transcription factors regulating expression patterns in response to cellular signals or nutrient status (such as PPARα and SREBP), and proteins involved in lipoprotein assembly/remodeling. These genes are implicated in numerous physiological processes including energy balance and membrane composition. Alterations or dysregulation among these genes contribute to major diseases such as cardiovascular disorders—where they influence cholesterol/lipoprotein profiles—neurodegenerative diseases like Alzheimer’s through effects on brain lipid homeostasis, cancer via changes supporting tumor growth/metabolism, obesity/metabolic syndrome, among others. While many individual "lipid metabolism regulation" proteins are considered therapeutic targets—with several drugs already approved targeting them—the term itself does not refer to one discrete molecular entity but rather an entire functional class spanning multiple protein families. Therefore it is not appropriate to treat "lipid metabolism regulation gene" itself as a canonical drug target; instead each member should be considered individually for structured data purposes. “Current therapeutic targets for lipid-related cardiovascular risk primarily include Lp(a), HDL-C, LDL-C, ABCA1, ANGPTL3, APOC3,CETP , PCSK9 ,and PPARα…most drug developments targeting these molecules are still in clinical or preclinical stages.” [1] “APOE,TREM2 ,APOJ,PICALM,SREBP‐2 ,ABCA1,and ABCA7 are involved in lipid trafficking and metabolism…This study identified differentially expressed lipid-metabolism–related genes…emphasizing their role …and potential therapeutic targets.” [2]
Varies by individual target within the group. Examples include: - Inhibition of cholesterol synthesis enzymes - Modulation of lipoprotein processing or clearance from plasma - Activation or inhibition of nuclear receptors regulating transcription of metabolic genes
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid metabolism regulation gene.